AC
NTGN

Athanor Capital’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Athanor Capital’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-547,651
Closed -$1.45M – 591
2020
Q1 		$1.45M Buy
+547,651
New +$898K 0.09% 90

Athanor Capital's NTGN Position: Q2 2020 in Review

Athanor Capital sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 547,651 shares — an estimated $1.45M sold.

Athanor Capital first reported a position in NTGN in Q1 2020 and held it in 1 quarter. The position peaked at $1.45M in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Athanor Capital reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Athanor Capital sold 547,651 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $1.45M.
  • Athanor Capital first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Athanor Capital's Neon Therapeutics, Inc. Common Stock position peaked at $1.45M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Athanor Capital's 13F filing for Q2 2020, filed 13 Aug 2020.